Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in BMC Neurol

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    December 2018
  1. SANDELIUS A, Cullen NC, Kallen A, Rosengren L, et al
    Transient increase in CSF GAP-43 concentration after ischemic stroke.
    BMC Neurol. 2018;18:202.
    PubMed     Text format     Abstract available


    September 2018
  2. SABBAGH MN, Shi J, Lee M, Arnold L, et al
    Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings.
    BMC Neurol. 2018;18:155.
    PubMed     Text format     Abstract available


    July 2018
  3. LIN Y, Li B, Tang H, Xu Q, et al
    Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology.
    BMC Neurol. 2018;18:103.
    PubMed     Text format     Abstract available


    May 2018
  4. LI J, Wu L, Tang Y, Zhou A, et al
    Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer's disease.
    BMC Neurol. 2018;18:65.
    PubMed     Text format     Abstract available


    April 2018
  5. MIYAKE K, Hara T, Oshima E, Kawada K, et al
    Creutzfeldt-Jakob disease with Alzheimer pathology, presenting with status epilepticus following repeated partial seizures: a case report and literature review.
    BMC Neurol. 2018;18:54.
    PubMed     Text format     Abstract available


    January 2018
  6. HUANG X, Liu H, Li X, Guan L, et al
    Revealing Alzheimer's disease genes spectrum in the whole-genome by machine learning.
    BMC Neurol. 2018;18:5.
    PubMed     Text format     Abstract available


  7. FENG L, Liao YT, He JC, Xie CL, et al
    Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease.
    BMC Neurol. 2018;18:4.
    PubMed     Text format     Abstract available


    October 2017
  8. LEE CC, Hsu SW, Huang CW, Chang WN, et al
    Effects of Homocysteine on white matter diffusion parameters in Alzheimer's disease.
    BMC Neurol. 2017;17:192.
    PubMed     Text format     Abstract available


  9. TU MC, Huang WH, Hsu YH, Lo CP, et al
    Correction to: Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer's disease.
    BMC Neurol. 2017;17:189.
    PubMed     Text format    


    July 2017
  10. TU MC, Huang WH, Hsu YH, Lo CP, et al
    Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer's disease.
    BMC Neurol. 2017;17:144.
    PubMed     Text format     Abstract available


    May 2017
  11. WALLIN A, Kapaki E, Boban M, Engelborghs S, et al
    Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    BMC Neurol. 2017;17:102.
    PubMed     Text format     Abstract available


  12. KANETA T, Katsuse O, Hirano T, Ogawa M, et al
    Voxel-wise correlations between cognition and cerebral blood flow using arterial spin-labeled perfusion MRI in patients with Alzheimer's disease: a cross-sectional study.
    BMC Neurol. 2017;17:91.
    PubMed     Text format     Abstract available


    April 2017
  13. LANE CA, Parker TD, Cash DM, Macpherson K, et al
    Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.
    BMC Neurol. 2017;17:75.
    PubMed     Text format     Abstract available


  14. ABUSHOUK AI, Elmaraezy A, Aglan A, Salama R, et al
    Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials.
    BMC Neurol. 2017;17:66.
    PubMed     Text format     Abstract available


    February 2017
  15. TAI SY, Chen CH, Chien CY, Yang YH, et al
    Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study.
    BMC Neurol. 2017;17:40.
    PubMed     Text format     Abstract available


    January 2017
  16. LI F, Chen S, Wei C, Jia J, et al
    Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
    BMC Neurol. 2017;17:15.
    PubMed     Text format     Abstract available


    November 2016
  17. SHAFI O
    Inverse relationship between Alzheimer's disease and cancer, and other factors contributing to Alzheimer's disease: a systematic review.
    BMC Neurol. 2016;16:236.
    PubMed     Text format     Abstract available


  18. DEMING Y, Black K, Carrell D, Cai Y, et al
    Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
    BMC Neurol. 2016;16:217.
    PubMed     Text format     Abstract available


    August 2016
  19. SCHONECKER S, Brendel M, Huber M, Vollmar C, et al
    Applied multimodal diagnostics in a case of presenile dementia.
    BMC Neurol. 2016;16:131.
    PubMed     Text format     Abstract available


    June 2016
  20. BLANCO MARTIN E, Ugarriza Serrano I, Elcoroaristizabal Martin X, Galdos Alcelay L, et al
    Dysexecutive syndrome in amnesic mild cognitive impairment: a multicenter study.
    BMC Neurol. 2016;16:88.
    PubMed     Text format     Abstract available


    May 2016
  21. CHEN GQ, Sheng C, Li YX, Yu Y, et al
    Neuroimaging basis in the conversion of aMCI patients with APOE-epsilon4 to AD: study protocol of a prospective diagnostic trial.
    BMC Neurol. 2016;16:64.
    PubMed     Text format     Abstract available


    January 2016
  22. BERGE G, Sando SB, Albrektsen G, Lauridsen C, et al
    Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.
    BMC Neurol. 2016;16:180.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: